Date	Period	Revenue/Estimate	Earnings Call
Apr 24, 2025	2025/Q1	-- / 10.252B	--
Jan 30, 2025	2024/Q4	-- / 10.739B	--
Oct 25, 2024	2024/Q3	13.438B / 12.670B	--
Jul 25, 2024	2024/Q2	10.745B / 10.377B	--
Apr 25, 2024	2024/Q1	10.464B / 10.208B	--

DatePeriodRevenue/EstimateEarnings Call

Apr 24, 20252025/Q1-- / 10.252B--

Jan 30, 20252024/Q4-- / 10.739B--

Oct 25, 20242024/Q313.438B / 12.670B--

Jul 25, 20242024/Q210.745B / 10.377B--

Apr 25, 20242024/Q110.464B / 10.208B--

Unlock Free Earnings Estimates

Open Account

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 25, 2024 12:42 ET

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25, 2024 11:48 ET

6-K: 2024 Half-Year Financial Report

Jul 25, 2024 10:29 ET

Sanofi | 6-K: Colletion of Recent Announcements

May 2, 2024 15:56 ET

SNY Sanofi

Sanofi Key Stats